Examples of Hematology Combination Codes –ICD-10-CM • D57.211 – Sickle-cell/Hb-C disease with acute chest syndrome • D57.212 – Sickle-cell/Hb-C disease with splenic sequestration • D57.411 – Sickle-cell thalassemia with acute chest syndrome • D57.412 – Sickle-cell thalassemia with splenic sequestration
You can practice Hematology ICD-10 codes with our free online flashcards! Go to Flashcards now! Chapter 1 - Certain infectious and parasitic diseases (A00-B99) + Section B95-B97 - Bacterial and viral infectious agents (B95-B97) + Section B20 - Human immunodeficiency virus [HIV] disease (B20) Chapter 2 - Neoplasms (C00-D49) + Section D37-D48 -
Oct 01, 2021 · Z71.89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z71.89 became effective on October 1, 2021. This is the American ICD-10-CM version of Z71.89 - other international versions of ICD-10 Z71.89 may differ.
ICD-10 Conversion for Hematology. On October 1, 2015, all healthcare business transactions in the United States must convert from the use of the ninth version of the International Classification of Disease (ICD-9) to the tenth version (ICD-10). This is a complete restructuring of the diagnosis codes used by hematologists every day. The transition will take place on a single day so there …
ICD-10 Digit Description; 0 unspecified site 1 lymph nodes of head, face, and neck 2 intrathoracic lymph nodes 3 intra-abdominal lymph nodes 4 lymph nodes of axilla and upper limb 5 lymph nodes of inguinal region and lower limb 6 intrapelvic lymph nodes 7 spleen 8 lymph nodes of multiple sites 9 extranodal and solid organ sites
ICD-10: | Z71.89 |
---|---|
Short Description: | Other specified counseling |
Long Description: | Other specified counseling |
Test Name: | TYPE/RH/SCREEN, ANTENATAL RH IMMUNE GLOBULIN |
---|---|
Alias: | RhIG T&S Type and Screen |
CPT Code(s): | 86900 86901 86850 |
Test Includes: | ABO Rh Antibody Screen |
Preferred Specimen: | 6.0 mL whole blood |
195.2 Abdominal cavity#N#173.5 Abdominal wall (skin)#N#154.3 Anus (anal)#N#156.9 Biliary tract (cholangiocarcinoma), unspecified site#N#188.9 Bladder, unspecified site#N#233.7 Bladder, in situ#N#191.9 Brain, unspecified site#N#174.9 Breast, female, unspecified site#N#233.0 Breast, in situ (DCIS)#N#175.9 Breast, male, unspecified site#N#162.9 Bronchus, unspecified site#N#180.9 Cervix (cervival), unspecified site#N#233.1 Cervix uteri, in situ#N#170.9 Chondrosarcoma#N#153.9 Colon (colorectal), unspecified site#N#182.0 Endometrium (endometrial)#N#150.9 Esophagus (esophageal), unspecified site#N#170.9 Ewing's sarcoma#N#159.9 Gastrointestinal tract, unspecified site#N#184.9 Genital, female, unspecified site#N#187.9 Genital, male, unspecified site#N#153.9 Intestine (bowel), large, unspecified site#N#152.9 Intestine (bowel), small, unspecified site#N#176.9 Kaposi's Sarcoma, unspecified site#N#189.0 Kidney (renal)#N#155.0 Liver (hepatocellular), primary#N#155.2 Liver, not specified as primary or secondary#N#162.9 Lung (adenocarcinoma/squamous cell carcinoma), unspecified site#N#209.36 Merkel cell carcinoma#N#145.9 Mouth, unspecified site#N#147.9 Nasopharynx, unspecified site#N#170.9 Osteosarcoma#N#183.0 Ovary (ovarian)#N#157.9 Pancreas (pancreatic), unspecified part#N#163.8 Pleura/contiguous sites#N#185 Prostate#N#233.4 Prostate, in situ#N#154.1 Rectum#N#158.0 Retroperitoneum#N#171.9 Rhabdosarcoma#N#142.9 Salivary gland, unspecified site#N#171.9 Sarcoma, connective or soft tissue#N#172.9 Skin, melanoma, unspecified site#N#173.9 Skin, unspecified malignancy, unspecified site#N#151.9 Stomach, unspecified site#N#186.9 Testis (testicular), unspecified site#N#195.1 Thorax#N#193 Thyroid#N#141.9 Tongue, unspecified site#N#199.1 Unknown primary#N#179 Uterus (uterine), unspecified site.
207.00 Acute erythremia & erythroleukemia#N#207.00 Acute lymphoid leukemia (ALL)#N#206.00 Acute monocytic leukemia#N#205.00 Acyte myeloid leukemia (AML)#N#208.00 Acute leukemia, unspecified#N#277.30 E85.9 Amyloidosis#N#208.10 Chronic leukemia, unspecified#N#204.10 Chronic lymphoid leukemia (CLL)#N#206.10 Chronic monocytic leukemia#N#205.10 Chronic myeloid leukemia (CML)#N#202.40 Hairy cell leukemia#N#207.20 Megakaryocytic leukemia#N#273.1 D47.2 Monoclonal gammopathy of undetermined significance (MGUS)#N#203.00 C90.0 [0-2] Multiple myeloma (MM)#N#203.10 C90.1 [0-2] Plasma cell leukemia.
284.11 Antineoplastic chemotherapy induced pancytopenia#N#285.3 Antineoplastic chemotherapy induced anemia#N#995.29 Complication of chemotherapy#N#999.81 Extravasation of vesicant chemotherapy#N#V07.39 Need for other prophylactic chemotherapy#N#V58.11 Encounter for antineoplastic chemotherapy#N#V66.2 Convalescence following chemotherapy#N#V67.2 Follow-up examination following chemotherapy#N#V87.41 Personal history of antineoplastic chemotherapy.